Postdoctoral Fellow in Malignant Hematology
Job posting number: #7184060 (Ref:hlj_49855)
Posted: October 2, 2023
Application Deadline: Open Until Filled
Postdoctoral Fellow in Malignant Hematology
The Padron Lab studies the molecular pathogenesis of Chronic Myelomonocytic Leukemia (CMML) with the goal of identifying novel therapeutic vulnerabilities. CMML is a rare and lethal hematopoietic malignancy characterized by a characteristic classical monocytosis and a propensity to transform to Acute Myeloid Leukemia (AML). Interestingly, the majority of CMML patients present in a clinically asymptomatic state for periods of weeks to months before progressing to a lethal disease that clinically manifests via a heterogenous group of symptoms. There are no FDA approved therapies that have been demonstrated to alter the natural history of disease and the goal of our laboratory is to provide the preclinical evidence to increase the armamentarium available to clinicians treating this disease. Although our focus is centrally on CMML, our work aims to address questions in the field that can be more broadly applicable to other types of leukemias and cancers.
- The candidate will gain experience in preclinical and translational research in hematologic oncology.
- The candidate will have the opportunity to test novel treatments for leukemia in mouse models and work with a collaborative team comprised of clinicians, cancer biologists and computational biologists.
- Moffitt integrates excellent patient care with cutting-edge clinical and basic research. Having a cancer hospital on-site provides unique opportunities for translational research.
- Outstanding mentorship from expert faculty with wide-ranging funded research programs including T32 Training Grants.
- You will be encouraged and supported to apply for training grants.
The Ideal Candidate:
- Candidates must be experienced in molecular biology and cell biology techniques including mammalian cell culture, qPCR, western blotting, DNA/RNA manipulation
- Must be well-organized and detail-oriented with the ability to maintain accurate records
- Must have a strong work ethic and desire to drive projects independently
- Experience with mouse models of cancer and flow cytometry is highly desirable
- Design and execute experiments; analyze and interpret data
- Work independently as well as part of a collaborative team
- Present research findings in lab meetings, conferences and journal publications
Credentials and Qualifications:
- Ph.D or MD/Ph.D in biology, biochemistry, molecular biology, or a related field.
- Should have at least one first author publication.
Moffitt Postdocs are provided with Medical (Moffitt covers premium for team member) effective upon start date and eligible for Dental, Vision, Paid Time Off, Retirement, Parental Leave and more. You may be eligible for relocation assistance per policy. Reasons to relocate, aside from the sunshine, beaches and year-round outdoor recreation associated with the Gulf Coast of Florida, Tampa is a thriving metropolitan city, which has become a hub for ground-breaking research, welcoming individuals from around the globe. This diverse city is engulfed with rich culture, year-round activities for all, beautiful beaches, amazing cuisine and so much more. We strive for work/life balance.
If you have the vision, passion, and dedication to contribute to our mission,
then we have a place for you.
How to Apply: Interested applicants should complete a formal application via www.Moffitt.org/careers site and additionally send a single PDF file that includes a cover letter summarizing their research training and accomplishments, a personal statement of scientific interests and goals, a current CV with recent publications, and contact information for three references to Dr. Eric Padron ([email protected])
Mission To create a Moﬃtt culture of diversity, equity, and inclusion as we strive to contribute to the prevention and cure of cancer. Vision To advance and accelerate a culture of access, equity, and inclusion. Diversity is a priority at Moffitt and is meant "to promote a culture of diversity and inclusion as we contribute to the prevention and cure of cancer." The Enterprise Equity Department focuses its efforts on eliminating those obstacles to an individual’s ability to exist within their personal comfort zone at the cancer center. Everyone is important to meeting this priority. Addressing and responding to diversity and inclusion fosters an environment where mutual respect for diverse cultures, communication styles, languages, customs, beliefs, values, traditions, experiences and other ways in which we identify ourselves, is the expectation.